<!DOCTYPE html>
<html lang="en-us">
  <head>
	<meta name="generator" content="Hugo 0.85.0" />
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    
    <title>fallingstar-Daily-rss | Fallingstar Daily R</title>
    <link rel="stylesheet" href="/css/style.css" />
    <link rel="stylesheet" href="/css/fonts.css" />
    <link href="//cdn.bootcss.com/highlight.js/9.12.0/styles/github.min.css" rel="stylesheet">

  </head>

  <body>
    <nav class="header">
      <div class="banner">
<a href="/" class="text">
&Ffr;&Afr;&Lfr;&Lfr;&Ifr;&Nfr;&Gfr;&Sfr;&Tfr;&Afr;&Rfr; &Dfr;&Afr;&Ifr;&Lfr;&Yfr; &Rfr;
</a>
</div>

      <div class="head-meta">
      
        <span>fallingstar-Daily-rss</span>
        <span>2024-04-05</span>
      
      </div>
    </nav>


<div class="container">
<main class="list">

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38576222/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240405180803&amp;v=2.18.0.post9&#43;e462414">Biological Variation Estimates for Plasma Copeptin and Clinical Implications</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38576222-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240405180803-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: The availability of BV data allows for refined APS and associated II, and RCVs applicable as aids in the serial monitoring of patients with specific diseases such as heart failure. The BV estimates are only applicable in subjects who abstained from oral intake due to the rapid and marked effects of fluids on copeptin &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38576796/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240405180803&amp;v=2.18.0.post9&#43;e462414">Is there an immunological cross-reactivity of antibodies to the myelin oligodendrocyte glycoprotein and coronaviruses?</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38576796-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240405180803-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Recent reports indicated that myelin oligodendrocyte glycoprotein antibody-associated disease might be a rare complication after severe acute respiratory syndrome coronavirus 2 infection or vaccination. It is unclear whether this is an unspecific sequel of infection or vaccination or caused by possible immunological cross-reactivity of severe acute respiratory syndrome coronavirus 2 proteins and myelin oligodendrocyte glycoprotein. The aim of this study was therefore to elucidate whether &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38577107/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240405180803&amp;v=2.18.0.post9&#43;e462414">Disruption of CD47-SIRPα signaling restores inflammatory function in tumor-associated myeloid-derived suppressor cells</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38577107-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240405180803-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Myeloid-derived suppressor cells (MDSCs) are a heterogeneous immune population with diverse immunosuppressive functions in solid tumors. Here, we explored the role of the tumor microenvironment in regulating MDSC differentiation and immunosuppressive properties via signal-regulatory protein alpha (SIRPα)/CD47 signaling. In a murine melanoma model, we observed progressive increases in monocytic MDSCs and monocyte-derived dendritic cells that exhibited potent T cell-suppressive capabilities. &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38577494/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20240405180744&amp;v=2.18.0.post9&#43;e462414">Resolution of metastatic neck nodes associated with a periauricular cutaneous squamous cell carcinoma after intranodal injection of talimogene laherparepvec</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38577494-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20240405180744-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38577791/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240405180803&amp;v=2.18.0.post9&#43;e462414">Exploring evolutionary trajectories in ovarian cancer patients by longitudinal analysis of ctDNA</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38577791-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240405180803-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: We demonstrate that tracing the temporal heterogeneity of ctDNA, even below exome scale resolution, deciphers evolutionary trajectories in ovarian cancer. Furthermore, we describe two evolutionary patterns that may help to identify relapse seeding clones for targeted &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38577801/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240405180803&amp;v=2.18.0.post9&#43;e462414">Navigating data standards in public health: A brief report from a data-standards meeting</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38577801-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240405180803-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38577820/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240405180803&amp;v=2.18.0.post9&#43;e462414">Antibodies against high-risk human papillomavirus proteins as markers for noncervical HPV-related cancers in a Black South African population, according to HIV status</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38577820-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240405180803-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Human papillomavirus (HPV) proteins may elicit antibody responses in the process toward HPV-related malignancy. However, HPV seroepidemiology in noncervical HPV-related cancers remains poorly understood, particularly in populations with a high prevalence of human immunodeficiency virus (HIV). Using a glutathione S-transferase-based multiplex serology assay, antibodies against E6, E7 and L1 proteins of HPV16 and HPV18 were measured in sera of 535 cases of noncervical HPV-related cancers (anal &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38577925/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240405180803&amp;v=2.18.0.post9&#43;e462414">[Retracted] Sulforaphane sensitizes human cholangiocarcinoma to cisplatin via the downregulation of anti‑apoptotic proteins</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38577925-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240405180803-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Following the publication of the above article and a corrigendum that was published in October 2023 to address the issue of misplaced control β‑actin western blots comparing between Figs. 3 and 4A (doi: 10.3892/or.2023.8646), an attentive reader drew to the authors' attention that the first author had apparently made additional unreported corrections to the revised version of Fig. 4 presented in the corrigendum. Although these image discrepancies did not alter the study&rsquo;s primary &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38578306/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240405180803&amp;v=2.18.0.post9&#43;e462414">Treatment response as surrogate to predict risk for disease progression in pediatric medulloblastoma with persistent MRI lesions after first-line treatment</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38578306-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240405180803-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Overall response and extent of lesions can function as surrogate parameters to predict outcomes in pediatric MB patients with persistent lesions after first-line therapy. Especially in case of solitary persistent medulloblastoma MRI lesion, additional therapy was not beneficial. Therefore, treatment response, extent/kind of residual lesions and further diagnostic information needs consideration for indication of additional treatments for persisting &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38578500/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240405180803&amp;v=2.18.0.post9&#43;e462414">Correction to: Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38578500-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240405180803-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38578535/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240405180803&amp;v=2.18.0.post9&#43;e462414">&#34;The anxiety coming up to every scan-It destroyed me&#34;: A qualitative study of the lived experience of cytomegalovirus infection during pregnancy</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38578535-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240405180803-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Serological diagnosis of maternal CMV infection during pregnancy can have severe and prolonged psychological impacts on parents, regardless of the pregnancy outcome. Improving healthcare professionals' knowledge and public awareness are essential before widespread serological screening can be responsibly introduced. Healthcare administrators that are considering implementing a prenatal screening program for secondary prevention of fetal CMV infection should pay attention to &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38578671/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240405180803&amp;v=2.18.0.post9&#43;e462414">Attributes, Methods, and Frameworks Used to Evaluate Wearables and Their Companion mHealth Apps: Scoping Review</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38578671-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240405180803-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Our scoping review identified the types and categories of wearable devices and mHealth apps, their frequency of use in studies, and their implementation in the medical context. In addition, we examined the usability evaluation of these technologies: methods, attributes, and frameworks. Within the array of available wearables and mHealth apps, health care providers encounter the challenge of selecting devices and companion apps that are effective, user-friendly, and compatible &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/O8hWkzHD6">Stanford斯坦福大学Matthew Porteus组在Cell Stem Cell发表了一项重要的HIV治愈研究。Matthew Porteus在医疗和科技领域非常有名，他是Stanford毕业的MD-PhD，现...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-o8hwkzhd6/">
    
    
    
    
    
      
    
    Stanford斯坦福大学Matthew Porteus组在Cell Stem Cell发表了一项重要的HIV治愈研究。Matthew Porteus在医疗和科技领域非常有名，他是Stanford毕业的MD-PhD，现在是Stanford MD-PhD项目（MSTP）副主任，并且是CRISPR Therapeutics的创建者之一。他的研究组发表的这项研究是一项重要的探索性HIV治愈研究，通过CRISPR-Cas9编辑造血干细胞（HSCs）CCR5来抵御R5和X4嗜性的HIV-1，使造血干细胞移植（HCT）后HIV无法感染移植物细胞。<!-- raw HTML omitted --><!-- raw HTML omitted -->目前全世界有5例HIV治愈病例全部是通过CCR5Δ32 HCT实现的（<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg">https://h5.sinaimg</a>. &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/O8jDKix0j">Science发表了一篇评论文章引用了IHME Chris Murray数据指出，全球出生率持续下降，可能将在2030年提前出现人口增长拐点。按照传统的人口学理论（replacement fe...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-o8jdkix0j/">
    
    
    
    
    
      
    
    Science发表了一篇评论文章引用了IHME Chris Murray数据指出，全球出生率持续下降，可能将在2030年提前出现人口增长拐点。按照传统的人口学理论（replacement fertility rate）：平均每个妇女需要生育2.1个子女（TFR=2.1）才能抵消人口死亡率，使总人口稳定。TFR超过2.1则会出现人口增长；否则人口会下降。之前的很多研究预测，2056年之后，TFR将小于2.1，之后全人类会出现人口下降。但这篇文章引用的模型指出，2030年全人类可能就会出现TFR小于2.1的拐点，而TFR小于2.1后，随着老年人死亡，人类将在2060年出现全球人口绝对数量下降。&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/4a994b1dgy1hofzabmqpxj247n4dfe81.jpg%22">https://tvax1.sinaimg.cn/large/4a994b1dgy1hofzabmqpxj247n4dfe81.jpg&quot;</a> referrerpolicy=&ldquo;no-ref &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/O8jdNkax4">Fred Hutch的Larry Corey组（网页链接）在JCI发表了一篇HIV治愈研究论文，非常有意思。该研究直接用表达anti-PD-1 CAR-T试图治愈HIV，之所以觉得这项研究有意思...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-o8jdnkax4/">
    
    
    
    
    
      
    
    Fred Hutch的Larry Corey组（<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->网页链接<!-- raw HTML omitted --><!-- raw HTML omitted -->）在JCI发表了一篇HIV治愈研究论文，非常有意思。该研究直接用表达anti-PD-1 CAR-T试图治愈HIV，之所以觉得这项研究有意思，是因为PD-1+ Tfh细胞可能是HIV储藏库（&lt;a href=&ldquo;<a href="https://weibo.com/1251560221/4164">https://weibo.com/1251560221/4164</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/O8i6D2NwB">必胜客的咖啡连水都算不上[怒][怒][怒][怒][怒][怒][怒][怒]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-o8i6d2nwb/">
    
    
    
    
    
      
    
    必胜客的咖啡连水都算不上<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img alt=&quot;[怒]&quot; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/O8i6n6uPk">说句实话，本淄博人今年应该能去吃一次淄博烧烤了[二哈]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-o8i6n6upk/">
    
    
    
    
    
      
    
    说句实话，本淄博人今年应该能去吃一次淄博烧烤了<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O8hCdmOHa">转发微博 - 转发 @山下美月教会:&amp;ensp;山下美月#山下美月手机博# 240404.2「材料」之后还开了会啥的哦—忙碌了之后经纪人说 你是不是还没吃饭就给了我饭团和猪肉...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o8hcdmoha/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@山下美月教会<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->山下美月<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%25E">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O8kWtCLYN">摸摸肚肚 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里via.seventeenjp_mag ins 顶筆TEN使的微博视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o8kwtclyn/">
    
    
    
    
    
      
    
    摸摸肚肚<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->via.seventeenjp_mag ins &lt;a href=&ldquo;<a href="https://video.weibo.com/show?fid=1034:5019757385023526%22">https://video.weibo.com/show?fid=1034:5019757385023526&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O8n4fbwVU">转发微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里天號星 院线发布 媒体图 [图片][图片][图片][图片][图片][图片][图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o8n4fbwvu/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->天號星 院线发布 媒体图 &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax4.sinaimg.cn/large/006z6nxLgy1hog8rwl31lj30xc0m8t9k.jpg%22">https://tvax4.sinaimg.cn/large/006z6nxLgy1hog8rwl31lj30xc0m8t9k.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O8n4hdpRq">转发微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里via.Venue 101 官X 顶筆TEN使的微博视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o8n4hdprq/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->via.Venue 101 官X <!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O8n4qEz9B">转发微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里GEKI×CINE『天號星』 初日舞台相关视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o8n4qez9b/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->GEKI×CINE『天號星』 初日舞台相关视频 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;video &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O8n7eqJBY">今天（？其实是昨天了）也过得很开心！我煎的蛋姐姐包的锅贴配白象的火鸡面真的嘎嘎好吃今天打牌特别旺终于赢钱了！（不过拿去加油了[举车] [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o8n7eqjby/">
    
    
    
    
    
      
    
    今天（？其实是昨天了）也过得很开心！<!-- raw HTML omitted -->我煎的蛋姐姐包的锅贴配白象的火鸡面真的嘎嘎好吃<!-- raw HTML omitted -->今天打牌特别旺终于赢钱了！（不过拿去加油了<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O8nf94yDX">这种事情不要啊[单身狗] - 转发 @山下美月教会:&amp;ensp;山下美月#山下美月手机博# 240405.4「晚安美月」和害羞鬼做了同样的表情眼睛真可怕明天有幸出演Venue101节...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o8nf94ydx/">
    
    
    
    
    
      
    
    这种事情不要啊<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@山下美月教会<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://n.sinaimg.cn/photo/5213b46e/20180926/timeline_card_small_s">https://n.sinaimg.cn/photo/5213b46e/20180926/timeline_card_small_s</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O8ngmydMR">yama桑什么时候来打扰一下我们哦噜耐头泥嘭</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o8ngmydmr/">
    
    
    
    
    
      
    
    yama桑什么时候来打扰一下我们哦噜耐头泥嘭  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O8omo0c3e">一本同心词一本循循，真得劲</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o8omo0c3e/">
    
    
    
    
    
      
    
    一本同心词一本循循，真得劲  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O8ooNov6R">月绪真甜</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o8oonov6r/">
    
    
    
    
    
      
    
    月绪真甜  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/O8hMJn0yf">恭喜咲月加入loveit家庭（每週五演出） [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-o8hmjn0yf/">
    
    
    
    
    
      
    
    恭喜咲月加入loveit家庭（每週五演出） <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/O8iNKvyMb">转发微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里via.seventeenjp_mag ins 顶筆TEN使的微博视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-o8inkvymb/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->via.seventeenjp_mag ins &lt;a href=&ldquo;<a href="https://video.weibo.com/show?fid=1034:5019757385023526%22">https://video.weibo.com/show?fid=1034:5019757385023526&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/O8jlQdbDs">璃果出演「有點心機又何妨」！ [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-o8jlqdbds/">
    
    
    
    
    
      
    
    璃果出演「有點心機又何妨」！ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/O8jqboHGX">分享图片 [图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-o8jqbohgx/">
    
    
    
    
    
      
    
    分享图片 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/O8ncNoRhO">清麗 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里天號星 院线发布 媒体图 [图片][图片][图片][图片][图片][图片][图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-o8ncnorho/">
    
    
    
    
    
      
    
    清麗<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->天號星 院线发布 媒体图 &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax4.sinaimg.cn/large/006z6nxLgy1hog8rwl31lj30xc0m8t9k.jpg%22">https://tvax4.sinaimg.cn/large/006z6nxLgy1hog8rwl31lj30xc0m8t9k.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/O8iLwlYvh">日本4月野榜（非官方）出炉，一力辽升至第一，广濑优一和关航太郎晋升前10，上野爱咲美进入前30#围棋#围棋 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-o8ilwlyvh/">
    
    
    
    
    
      
    
    日本4月野榜（非官方）出炉，一力辽升至第一，广濑优一和关航太郎晋升前10，上野爱咲美进入前30<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#围棋#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/O8jFjnKMn">严动虔这个斯蒂芬李行为太抽象了</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-o8jfjnkmn/">
    
    
    
    
    
      
    
    严动虔这个斯蒂芬李行为太抽象了  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/O8jGwawXU">今年日本头衔战，执白胜率90%（9胜1负）另外，佩戴眼镜的棋手胜率100%#围棋#围棋</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-o8jgwawxu/">
    
    
    
    
    
      
    
    今年日本头衔战，执白胜率90%（9胜1负）<!-- raw HTML omitted --><!-- raw HTML omitted -->另外，佩戴眼镜的棋手胜率100%<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#围棋#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/O8jyXdKkr">严动虔坚持贯彻落实什么局面都最后一秒下棋，然后盘10&#43;变半目胜负#围棋#围棋</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-o8jyxdkkr/">
    
    
    
    
    
      
    
    严动虔坚持贯彻落实什么局面都最后一秒下棋，然后盘10+变半目胜负<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#围棋#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->围棋<!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/O8k21dVIO">4月7日 下午2时 弈城围棋平台於之莹vs仲邑堇#围棋#围棋</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-o8k21dvio/">
    
    
    
    
    
      
    
    4月7日 下午2时 弈城围棋平台<!-- raw HTML omitted -->於之莹vs仲邑堇<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#围棋#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->围棋<!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/O8mRY0n9I">发布了头条文章：《日本棋院成立和院社对抗战——日本围棋百大奠基人004》 #围棋# 围棋 日本棋院成立和院社对抗战——日本围棋百大奠基人004 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-o8mry0n9i/">
    
    
    
    
    
      
    
    发布了头条文章：《日本棋院成立和院社对抗战——日本围棋百大奠基人004》 <!-- raw HTML omitted --><!-- raw HTML omitted -->#围棋#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->围棋<!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/O8munoAuM">发布了头条文章：《明知大学围棋系将被废除》 #围棋# 围棋 明知大学围棋系将被废除 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-o8munoaum/">
    
    
    
    
    
      
    
    发布了头条文章：《明知大学围棋系将被废除》 <!-- raw HTML omitted --><!-- raw HTML omitted -->#围棋#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->围棋<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;a href=&ldquo;<a href="https://weibo.com/">https://weibo.com/</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O8hYZ5Kpl">久保史绪里via.seventeenjp_mag ins 顶筆TEN使的微博视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o8hyz5kpl/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->via.seventeenjp_mag ins <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg.cn/upload/2015/0">https://h5.sinaimg.cn/upload/2015/0</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O8lMSskb8">久保史绪里天號星 院线发布 媒体图 [图片][图片][图片][图片][图片][图片][图片][图片][图片][图片][图片][图片][图片][图片][图片][图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o8lmsskb8/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->天號星 院线发布 媒体图 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/006z6nxLgy1hog8rwx2zvj">https://tvax1.sinaimg.cn/large/006z6nxLgy1hog8rwx2zvj</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O8lNNcvkL">久保史绪里via.Venue 101 官X 顶筆TEN使的微博视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o8lnncvkl/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->via.Venue 101 官X <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg.cn/upload/2015/09/25/3/">https://h5.sinaimg.cn/upload/2015/09/25/3/</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O8lQi1KBr">久保史绪里GEKI×CINE『天號星』 初日舞台相关视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o8lqi1kbr/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->GEKI×CINE『天號星』 初日舞台相关视频 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;video controls=&ldquo;controls&rdquo; poster=&ldquo;<a href="https://tvax2.sinaimg.cn/orj480/006z6nxLgy1hog9agyizqj30xw0j20wh.jpg%22">https://tvax2.sinaimg.cn/orj480/006z6nxLgy1hog9agyizqj30xw0j20wh.jpg&quot;</a> style=&ldquo;width: &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.zhihu.com/question/651622023/answer/3455020839">张敬信回答了问题: r语言主成分分析怎么画图？</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/www-zhihu-com-question-651622023-answer-3455020839/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.zhihu.com/question/651719017/answer/3455023522">张敬信回答了问题: r 语言和统计学有什么联系？</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/www-zhihu-com-question-651719017-answer-3455023522/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.zhihu.com/question/651810365/answer/3455456418">张敬信回答了问题: 怎么用excel筛选出每年365天连续数据中每个月第一天对应的数据呢？</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/www-zhihu-com-question-651810365-answer-3455456418/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/690796427">量子位发表了文章: AIGC还是二刺猿会玩：捏娃社区爆火，有脑洞就能当同人大佬</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-690796427/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/690811646">量子位发表了文章: 谷歌更新Transformer架构，更节省计算资源！50%性能提升</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-690811646/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/690812325">量子位发表了文章: 最懂AI的诺奖经济学得主去世，大模型关键技术受他研究启发</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-690812325/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/690813153">量子位发表了文章: 10万美元训出Llama-2级大模型！全华人打造新型MoE，贾扬清SD前CEO围观</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-05</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-690813153/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38571421/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240404180633&amp;v=2.18.0.post9&#43;e462414">The Virtual Child</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38571421-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240404180633-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    We are building the world&rsquo;s first Virtual Child-a computer model of normal and cancerous human development at the level of each individual cell. The Virtual Child will &ldquo;develop cancer&rdquo; that we will subject to unlimited virtual clinical trials that pinpoint, predict, and prioritize potential new treatments, bringing forward the day when no child dies of cancer, giving each one the opportunity to lead a full and healthy &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38571430/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240404180633&amp;v=2.18.0.post9&#43;e462414">Next Directions in the Neuroscience of Cancers Arising outside the CNS</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38571430-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240404180633-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The field of cancer neuroscience has begun to define the contributions of nerves to cancer initiation and progression; here, we highlight the future directions of basic and translational cancer neuroscience for malignancies arising outside of the central nervous &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38571605/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240404180633&amp;v=2.18.0.post9&#43;e462414">Macrophage diversity in human cancers: New insight provided by single-cell resolution and spatial context</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38571605-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240404180633-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    M1/M2 paradigm of macrophage plasticity has existed for decades. Now it becomes clear that this dichotomy doesn&rsquo;t adequately reflect the diversity of macrophage phenotypes in tumor microenvironment (TME). Tumor-associated macrophages (TAMs) are a major population of innate immune cells in the TME that promotes tumor cell proliferation, angiogenesis and lymphangiogenesis, invasion and metastatic niche formation, as well as response to anti-tumor therapy. However, the fundamental restriction &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38572271/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240404180633&amp;v=2.18.0.post9&#43;e462414">PsyCog: A computerised mini battery for assessing cognition in psychosis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38572271-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240404180633-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Despite the functional impact of cognitive deficit in people with psychosis, objective cognitive assessment is not typically part of routine clinical care. This is partly due to the length of traditional assessments and the need for a highly trained administrator. Brief, automated computerised assessments could help to address this issue. We present data from an evaluation of PsyCog, a computerised, non-verbal, mini battery of cognitive tests. Healthy Control (HC) (N = 135), Clinical High &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38572427/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240404180633&amp;v=2.18.0.post9&#43;e462414">Sex-specific changes in protein expression of membrane transporters in the brain cortex of 5xFAD mouse model of Alzheimer&#39;s disease</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38572427-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240404180633-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Membrane transporters playing an important role in the passage of drugs, metabolites and nutrients across the membranes of the brain cells have been shown to be involved in pathogenesis of Alzheimer&rsquo;s disease (AD). However, little is known about sex-specific changes in transporter protein expression at the brain in AD. Here, we investigated sex-specific alterations in protein expression of three ATP-binding cassette (ABC) and five solute carriers (SLC) transporters in the prefrontal cortex of &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38572654/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240404180633&amp;v=2.18.0.post9&#43;e462414">Treatment effects of empagliflozin in hospitalized heart failure patients across the range of left ventricular ejection fraction - Results from the EMPULSE trial</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38572654-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240404180633-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: The clinical benefit of empagliflozin proved consistent across LVEF categories in the EMPULSE trial. These results support early in-hospital initiation of empagliflozin regardless of &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38572868/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240404180633&amp;v=2.18.0.post9&#43;e462414">Mechanically operated signalling scaffolds</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38572868-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240404180633-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Cellular signalling is a complex process and involves cascades of enzymes that, in response to a specific signal, give rise to exact cellular responses. Signalling scaffold proteins organise components of these signalling pathways in space and time to co-ordinate signalling outputs. In this review we introduce a new class of mechanically operated signalling scaffolds that are built into the cytoskeletal architecture of the cell. These proteins contain force-dependent binary switch domains &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38572962/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20240404180602&amp;v=2.18.0.post9&#43;e462414">Household income and health-related quality of life in children receiving treatment for acute myeloid leukemia: Potential impact of selection bias in health equity research</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38572962-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20240404180602-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: While primary analyses suggested lower household income was associated with superior HRQOL, differential participation may have biased these results. Future studies should partner with patients/families to identify strategies for equitable participation in clinical &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38572962/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20240405180744&amp;v=2.18.0.post9&#43;e462414">Household income and health-related quality of life in children receiving treatment for acute myeloid leukemia: Potential impact of selection bias in health equity research</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38572962-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20240405180744-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: While primary analyses suggested lower household income was associated with superior HRQOL, differential participation may have biased these results. Future studies should partner with patients/families to identify strategies for equitable participation in clinical &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38573059/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240404180633&amp;v=2.18.0.post9&#43;e462414">Update on cancer predisposition syndromes and surveillance guidelines for childhood brain tumors</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38573059-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240404180633-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Tumors of the central nervous system (CNS) comprise the second most common group of neoplasms in childhood. The incidence of germline predisposition among children with brain tumors continues to grow as our knowledge on disease aetiology increases. Some children with brain tumors may present with non-malignant phenotypic features of specific syndromes (e.g. nevoid basal cell carcinoma syndrome, neurofibromatosis type 1 and type 2, DICER1 syndrome, and constitutional mismatch repair &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38573073/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240404180633&amp;v=2.18.0.post9&#43;e462414">Extracellular vesicle miRNAs drive aberrant macrophage responses in NSAID-exacerbated respiratory disease</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38573073-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240404180633-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Aberrant airway EV miRNA profiles may contribute to immune dysfunction and chronic type 2 inflammation in N-ERD. Let-7 family miRNAs represent targets for correcting aberrant macrophage activation and mediator responses in &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38573124/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240404180633&amp;v=2.18.0.post9&#43;e462414">Dual-Capped Helical Interface Mimics</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38573124-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240404180633-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Disruption of protein-protein interactions is medicinally important. Interface helices may be mimicked in helical probes featuring enhanced rigidities, binding to protein targets, stabilities in serum, and cell uptake. This form of mimicry is dominated by stapling between side chains of helical residues: there has been less progress on helical N-caps, and there were no generalizable C-caps. Conversely, in natural proteins, helicities are stabilized and terminated by C- and N-caps but &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38573126/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240404180633&amp;v=2.18.0.post9&#43;e462414">Myocardial Fibrosis in the Indeterminate Form of Chagas Disease: Harbinger of Cardiomyopathy or Silent Vestige?</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38573126-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240404180633-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38573332/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240404180633&amp;v=2.18.0.post9&#43;e462414">Role of robotics as a key platform for digital advancements in surgery</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38573332-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240404180633-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38573336/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240404180633&amp;v=2.18.0.post9&#43;e462414">Commentary of the SKLM to the EFSA opinion on risk assessment of N-nitrosamines in food</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38573336-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240404180633-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Dietary exposure to N-nitrosamines has recently been assessed by the European Food Safety Authority (EFSA) to result in margins of exposure that are conceived to indicate concern with respect to human health risk. However, evidence from more than half a century of international research shows that N-nitroso compounds (NOC) can also be formed endogenously. In this commentary of the Senate Commission on Food Safety (SKLM) of the German Research Foundation (DFG), the complex metabolic &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38573526/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240404180633&amp;v=2.18.0.post9&#43;e462414">A network of transcriptomic signatures identifies novel comorbidity mechanisms between schizophrenia and somatic disorders</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38573526-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240404180633-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The clinical burden of mental illness, in particular schizophrenia and bipolar disorder, are driven by frequent chronic courses and increased mortality, as well as the risk for comorbid conditions such as cardiovascular disease and type 2 diabetes. Evidence suggests an overlap of molecular pathways between psychotic disorders and somatic comorbidities. In this study, we developed a computational framework to perform comorbidity modeling via an improved integrative unsupervised machine &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38573603/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240404180612&amp;v=2.18.0.post9&#43;e462414">Soft tick relapsing fever in a traveler returning from Colorado</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38573603-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240404180612-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38573603/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240405180748&amp;v=2.18.0.post9&#43;e462414">Soft tick relapsing fever in a traveler returning from Colorado</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38573603-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240405180748-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38573604/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240404180612&amp;v=2.18.0.post9&#43;e462414">Targeting PD-L1 to treat ATLL?</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38573604-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240404180612-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38573604/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240405180748&amp;v=2.18.0.post9&#43;e462414">Targeting PD-L1 to treat ATLL?</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38573604-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240405180748-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38573605/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240404180612&amp;v=2.18.0.post9&#43;e462414">An evolving understanding of low VWF and type 1 VWD</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38573605-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240404180612-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38573605/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240405180748&amp;v=2.18.0.post9&#43;e462414">An evolving understanding of low VWF and type 1 VWD</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38573605-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240405180748-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38573606/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240404180612&amp;v=2.18.0.post9&#43;e462414">SETBP1 sets the stage</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38573606-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240404180612-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38573606/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240405180748&amp;v=2.18.0.post9&#43;e462414">SETBP1 sets the stage</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38573606-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240405180748-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38573607/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240404180612&amp;v=2.18.0.post9&#43;e462414">A treatment bridge for infants with hemophilia</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38573607-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240404180612-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38573607/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240405180748&amp;v=2.18.0.post9&#43;e462414">A treatment bridge for infants with hemophilia</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38573607-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240405180748-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38573608/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240404180612&amp;v=2.18.0.post9&#43;e462414">Uncovering new layers of Ph&#43; ALL biology</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38573608-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240404180612-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38573608/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240405180748&amp;v=2.18.0.post9&#43;e462414">Uncovering new layers of Ph&#43; ALL biology</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38573608-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240405180748-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38573609/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240404180612&amp;v=2.18.0.post9&#43;e462414">Glad tidings and joy for children with SCA</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38573609-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240404180612-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38573609/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240405180748&amp;v=2.18.0.post9&#43;e462414">Glad tidings and joy for children with SCA</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38573609-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240405180748-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38573610/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240404180612&amp;v=2.18.0.post9&#43;e462414">A way to &#34;mimic&#34; the pathophysiology of acquired SAA</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38573610-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240404180612-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38573610/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240405180748&amp;v=2.18.0.post9&#43;e462414">A way to &#34;mimic&#34; the pathophysiology of acquired SAA</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38573610-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240405180748-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38573762/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240404180633&amp;v=2.18.0.post9&#43;e462414">Perspectives of European Patient Advocacy Groups on Volunteer Registries and Vaccine Trials: VACCELERATE Survey Study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38573762-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240404180633-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Factors discouraging participants from joining vaccine trial registries or clinical trials primarily include concerns of the safety of novel vaccines and a lack of trust in those involved in vaccine development. These outcomes aid in identifying issues and setbacks in present registries, providing the VACCELERATE network with feedback on how to potentially increase participation and enrollment in trials across Europe. Development of European health communication strategies &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38574321/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240405180748&amp;v=2.18.0.post9&#43;e462414">Platelet-derived TGF-β1 induces functional reprogramming of myeloid-derived suppressor cells in immune thrombocytopenia</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38574321-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240405180748-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Platelet α-granules are rich in TGF-β1 which is associated with myeloid-derived suppressor cell (MDSC) biology. Responders to thrombopoietin receptor agonists (TPO-RAs) revealed a parallel increase in the number of both platelets and MDSCs. Here, anti-CD61 immune-sensitized splenocytes were transferred into severe combined immunodeficient mice to establish an active murine model of immune thrombocytopenia (ITP). Subsequently, we demonstrated that TPO-RAs augmented the inhibitory activities &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38574679/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240405180803&amp;v=2.18.0.post9&#43;e462414">Intravitreal Injections: Improving Sustainability by Reducing Clinical Waste</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38574679-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240405180803-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: A resource-saving approach to intravitreal injections can minimise the generation of clinical waste and its associated carbon footprint, thereby supporting &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38574786/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240405180803&amp;v=2.18.0.post9&#43;e462414">Inhibition of the potassium channel TASK-1 in human atria to reduce arrhythmogenesis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38574786-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240405180803-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38575192/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240405180803&amp;v=2.18.0.post9&#43;e462414">Optimal [&lt;sup&gt;18&lt;/sup&gt;F]FDG PET/CT Cutoff for Pathologic Complete Response in HER2-Positive Early Breast Cancer Patients Treated with Neoadjuvant Trastuzumab and Pertuzumab in the PHERGain Trial</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38575192-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240405180803-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The PHERGain trial investigated the potential of metabolic imaging to identify candidates for chemotherapy deescalation in human epidermal growth factor receptor 2 (HER2)-positive, invasive, operable breast cancer with at least 1 breast lesion evaluable by [^(18)F]FDG PET/CT. [^(18)F]FDG PET/CT responders were defined as patients with an SUV(max) reduction (ΔSUV(max)) of at least 40% in all of their target lesions after 2 cycles of trastuzumab and pertuzumab (HP) (with or without &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38575193/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20240405180744&amp;v=2.18.0.post9&#43;e462414">Detecting High-Dose Methotrexate-Induced Brain Changes in Pediatric and Young Adult Cancer Survivors Using [&lt;sup&gt;18&lt;/sup&gt;F]FDG PET/MRI: A Pilot Study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38575193-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20240405180744-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Significant improvements in treatments for children with cancer have resulted in a growing population of childhood cancer survivors who may face long-term adverse outcomes. Here, we aimed to diagnose high-dose methotrexate-induced brain injury on [^(18)F]FDG PET/MRI and correlate the results with cognitive impairment identified by neurocognitive testing in pediatric cancer survivors. Methods: In this prospective, single-center pilot study, 10 children and young adults with sarcoma (n = &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38575322/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240405180803&amp;v=2.18.0.post9&#43;e462414">Association of Carotid Artery Disease with Collateralization and Infarct Growth in Patients with Acute Middle Cerebral Artery Occlusion</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38575322-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240405180803-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: CAD of the ipsilateral ICA is an independent predictor of good collateral supply. Patients with CAD tend to have larger baseline infarct size but less infarct &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38575437/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240405180803&amp;v=2.18.0.post9&#43;e462414">The elective planetary health: Climate, environment and health at the faculty of medicine in Würzburg: Concept, didactic methods and evaluation results</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38575437-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240405180803-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: The elective can serve as an inspiration to tackle the challenge of taking the steps from knowledge to action in planetary health education. While an elective cannot replace the integration of all relevant aspects of planetary health into the main curriculum, it can serve as a space for piloting of future curricular educational interventions and offer opportunities for developing transformative &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38575636/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240405180803&amp;v=2.18.0.post9&#43;e462414">Large-scale assessment of physical activity in a population using high-resolution hip-worn accelerometry: the German National Cohort (NAKO)</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38575636-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240405180803-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Large population-based cohort studies utilizing device-based measures of physical activity are crucial to close important research gaps regarding the potential protective effects of physical activity on chronic diseases. The present study details the quality control processes and the derivation of physical activity metrics from 100 Hz accelerometer data collected in the German National Cohort (NAKO). During the 2014 to 2019 baseline assessment, a subsample of NAKO participants wore a &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38575832/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240405180803&amp;v=2.18.0.post9&#43;e462414">Diagnosis and therapy of patients with asthma in Germany. Results of the care study RELEVANT</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38575832-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240405180803-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: The results indicate a need for optimization, particularly regarding asthma control. This involves both a better assessment by patients' everyday life restrictions and modern ways of assessing asthma control in cooperation between GPs/internal medicine specialists and pulmonologists. One fifth of respondents do not see any differences between various ICS/LABA combinations in daily practice, although there are pharmacodynamic and pharmacokinetic &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38575962/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240405180803&amp;v=2.18.0.post9&#43;e462414">Association of the habitual dietary intake with the fatty liver index and effect modification by metabotypes in the population-based KORA-Fit study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38575962-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240405180803-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: The consumption of plant-based food groups, including nuts and whole grains, and diet quality, were associated with lower FLI values, whereas the intake of soft drinks and products of animal origin (meat, fish, eggs) were associated with a higher FLI. The observed statistically significant interactions with the metabotype for most food groups could help to develop targeted prevention strategies on a population-based level if confirmed in independent prospective &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38576030/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240405180803&amp;v=2.18.0.post9&#43;e462414">EpiDiP/NanoDiP: a versatile unsupervised machine learning edge computing platform for epigenomic tumour diagnostics</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38576030-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240405180803-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    DNA methylation analysis based on supervised machine learning algorithms with static reference data, allowing diagnostic tumour typing with unprecedented precision, has quickly become a new standard of care. Whereas genome-wide diagnostic methylation profiling is mostly performed on microarrays, an increasing number of institutions additionally employ nanopore sequencing as a faster alternative. In addition, methylation-specific parallel sequencing can generate methylation and genomic &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/O87OicpZ5">今天Marketplace做了深度报道，讲investors投资变化和我这条微博描述得一致。2023年美国VC投资比2022年减少了60%；投资startup资金减少了1/3。现在利率过高，inv...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-o87oicpz5/">
    
    
    
    
    
      
    
    今天Marketplace做了深度报道，讲investors投资变化和我这条微博描述得一致。2023年美国VC投资比2022年减少了60%；投资startup资金减少了1/3。现在利率过高，investor投资treasury bond（国债）回报率远高于投资企业。另外这个报道讲到大量VC自己也难raise，VC很多被locked up在之前投资。<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@子陵在听歌<!-- raw HTML omitted -->: 一些朋友问美国生物医学工业界最近的就业情况。我在置顶微博讲了生物医学PhD找工业界工作的一些技巧（<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1444865141/O896MpaTd">能换一次免夹名额不？//@来去之间:看完了，写的极好，以往作品都是从小人物入手，引出了当时的历史，这部小说更胜一筹，写出了天下[good] - 转发 @来去之间:&amp;ens...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1444865141-o896mpatd/">
    
    
    
    
    
      
    
    能换一次免夹名额不？//<!-- raw HTML omitted -->@来去之间<!-- raw HTML omitted -->:看完了，写的极好，以往作品都是从小人物入手，引出了当时的历史，这部小说更胜一筹，写出了天下<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@来去之间<!-- raw HTML omitted -->: &lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E6%AF%8F%E5%A4%A9%E8%BD%AC%E4%B8%AA%E5%B9%BF%E5%91%8A%23&amp;amp;isne">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E6%AF%8F%E5%A4%A9%E8%BD%AC%E4%B8%AA%E5%B9%BF%E5%91%8A%23&amp;amp;isne</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O882RcILU">🔻昨天花莲那个混一起的，看到一张单图还以为是假的，结果新闻都出来了……</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o882rcilu/">
    
    
    
    
    
      
    
    🔻昨天花莲那个混一起的，看到一张单图还以为是假的，结果新闻都出来了……  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O88aZxxlL">🔻法俄防长通电话了，你髪真是身躯柔软、立场灵活呢。🔻源：塔斯社官网 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o88azxxll/">
    
    
    
    
    
      
    
    🔻法俄防长通电话了，你髪真是身躯柔软、立场灵活呢。<!-- raw HTML omitted -->🔻源：塔斯社官网 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/2103074805/O8aOvt7Yc">别逼我造谣我跟你说[doge]//@王精啾咪啾咪_D:这个落款万合天宜的意思其实是万合天宜一哥[酷] - 转发 @Wink-小狗:&amp;ensp;万合天宜？沃日 徐马你们又幸福了 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-2103074805-o8aovt7yc/">
    
    
    
    
    
      
    
    别逼我造谣我跟你说<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->//<!-- raw HTML omitted -->@王精啾咪啾咪_D<!-- raw HTML omitted -->:这个落款万合天宜的意思其实是万合天宜一哥<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 &lt;a href=&ldquo;<a href="https://weibo.com/3175374657%22">https://weibo.com/3175374657&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/O8aTsAHIF">纯文盲大老爷在巡视商场后发表重要讲话，创造了0点GDP👿</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-o8atsahif/">
    
    
    
    
    
      
    
    纯文盲大老爷在巡视商场后发表重要讲话，创造了0点GDP👿  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O88yDn8pp">转发微博 - 转发 @彩带体操:&amp;ensp;柴田柚菜 #柴田柚菜# 【FRIDAY】乃木撮 Vol.271看到2位在一起时看起来很开心的样子，就会感到很幸福！📷小川彩 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o88ydn8pp/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@彩带体操<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->柴田柚菜<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E6%9F%B4%E7%94%B0">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E6%9F%B4%E7%94%B0</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O89Mbvu9n">转发微博 - 转发 @山下美月教会:&amp;ensp;山下美月#山下美月2nd写真集##女主角# 感谢观看SHOWROOM直播并预订了写真集✨✨其实，昨天发布的山下美月留言视频，是二次...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o89mbvu9n/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@山下美月教会<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->山下美月<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E5%B1%B1%E4%B8%8B%E7%BE%8E">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E5%B1%B1%E4%B8%8B%E7%BE%8E</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O8aANfQVc">转发微博 - 转发 @山下美月教会:&amp;ensp;山下美月#山下美月2nd写真集##女主角# 山下美月2nd写真集《女主角》特别企划✨在乃木坂想做的事情 身着乃木坂46历代打歌服...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o8aanfqvc/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@山下美月教会<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->山下美月<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E5%B1%B1%E4%B8%8B%E7%25">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E5%B1%B1%E4%B8%8B%E7%</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O8ba9tZ0v">笑鼠//@一吨水泥:小宰治 - 转发 @迷惑行為大賞:&amp;ensp;？？？ [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o8ba9tz0v/">
    
    
    
    
    
      
    
    笑鼠//<!-- raw HTML omitted -->@一吨水泥<!-- raw HTML omitted -->:小宰治<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@迷惑行為大賞<!-- raw HTML omitted -->: ？？？ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O8bJWzklE">转发微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里via.乃木坂46官X [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o8bjwzkle/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->via.乃木坂46官X &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/large/006z6nxLgy1hoeyouosvsj31kw15u4g7.jpg%22">https://tvax2.sinaimg.cn/large/006z6nxLgy1hoeyouosvsj31kw15u4g7.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O8dqZ6t1P">转发微博 - 转发 @山下美月教会:&amp;ensp;山下美月#山下美月手机博# 240404.1「迟了山」迟了山今天也是早上开始CanCam的拍摄—已经是秋天的拍摄了太快了吧—！都惊...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o8dqz6t1p/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@山下美月教会<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->山下美月<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E5%25">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E5%</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/O893uo4ex">好可愛！好可愛！好可愛！ [图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-o893uo4ex/">
    
    
    
    
    
      
    
    好可愛！好可愛！好可愛！ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/O8bHWctEo">還是好可愛[音乐] [图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-o8bhwcteo/">
    
    
    
    
    
      
    
    還是好可愛<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/O8dPqEWYa">姐控的日常 久保醬是ten使的微博视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-o8dpqewya/">
    
    
    
    
    
      
    
    姐控的日常 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保醬是ten使的微博视频<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;source src=&ldquo;<a href="https://f.video.weibocdn.com/o0/FEvToRoGlx08dPqsrCF2010412003ImB0E010.mp4?label=mp4">https://f.video.weibocdn.com/o0/FEvToRoGlx08dPqsrCF2010412003ImB0E010.mp4?label=mp4</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/O8dQ5mdDM">轉發微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里#shiorigram# 今晚25:00～（JST）东京电视网『日本怪奇ルポルタージュ』中我将有幸出演。请一定要观看…！！Nogiob...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-o8dq5mddm/">
    
    
    
    
    
      
    
    轉發微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23shio">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23shio</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/O8dQr9Rrm">上節目的通知好突然 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-o8dqr9rrm/">
    
    
    
    
    
      
    
    上節目的通知好突然 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/O8dRJopNX">眼睛笑成彎彎的月牙 [图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-o8drjopnx/">
    
    
    
    
    
      
    
    眼睛笑成彎彎的月牙 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/O8bsCDA4q">换了一个手机✓</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-o8bscda4q/">
    
    
    
    
    
      
    
    换了一个手机✓  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/O8dCmCMNI">发布了头条文章：《实力派棋手：铃木为次郎和濑越宪作——日本围棋百大奠基人003》 #围棋# 围棋 实力派棋手：铃木为次郎和濑越宪作——日本围棋百大奠基人003 [...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-o8dcmcmni/">
    
    
    
    
    
      
    
    发布了头条文章：《实力派棋手：铃木为次郎和濑越宪作——日本围棋百大奠基人003》 <!-- raw HTML omitted --><!-- raw HTML omitted -->#围棋#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->围棋&lt;/span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/O8djY36dv">发布了头条文章：《芝野虎丸完美控盘，拿到赛点》 #围棋# 围棋 芝野虎丸完美控盘，拿到赛点 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-o8djy36dv/">
    
    
    
    
    
      
    
    发布了头条文章：《芝野虎丸完美控盘，拿到赛点》 <!-- raw HTML omitted --><!-- raw HTML omitted -->#围棋#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->围棋<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;a &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O8bh8ksPg">久保史绪里via.乃木坂46官X [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o8bh8kspg/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->via.乃木坂46官X <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O8bYJ4Msa">久保史绪里#久保史绪里手机博# 2024.04.04 18:13「欸嘿嘿」今天19点开始（JST）是Nogiobi！有时间的话请一定要看！昨天也听了我的声音的人也请一定要看哦</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o8byj4msa/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%9A%23&amp;amp;isnewpage=">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%9A%23&amp;amp;isnewpage=</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O8c7kzdqZ">久保史绪里#shiorigram# 这之后19点开始（JST）是在SHOWROOM直播的Nogiobi～请一定要看～👔 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o8c7kzdqz/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#shiorigram#<!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O8c7PaoS2">久保史绪里via.NOGI46ann [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o8c7paos2/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->via.NOGI46ann <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O8c7unHqh">久保史绪里#久保史绪里手机博# 2024.04.04 21:03「预先」今天晚安了，虽然会有烦恼的日子，也会有要思考的日子，但会好起来的。怀着这样的信念，努力去做能努力...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o8c7unhqh/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%9A">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%9A</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O8dcczVGm">久保史绪里#shiorigram# 今晚25:00～（JST）东京电视网『日本怪奇ルポルタージュ』中我将有幸出演。请一定要观看…！！Nogiobi感谢大家 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o8dcczvgm/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#shiorigram#&lt;/spa &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O8dd0zxDH">久保史绪里via.乃木坂46 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o8dd0zxdh/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->via.乃木坂46 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/O88Dt7E1R">柯洁#柯柯b站动态搬运# [图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-o88dt7e1r/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->柯洁<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E6%9F%AF%E6%9F%AFb%E7%AB%99%E5%8A%A8%E6%80%81%E6%90%AC%E8%BF%90%23&amp;amp;extparam=%23%E6%9F%AF%E6%9F%AFb%E7%AB%99%E5%8A%A8%E6%80%81%E6%90%AC%E8%BF%90%23%22">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E6%9F%AF%E6%9F%AFb%E7%AB%99%E5%8A%A8%E6%80%81%E6%90%AC%E8%BF%90%23&amp;amp;extparam=%23%E6%9F%AF%E6%9F%AFb%E7%AB%99%E5%8A%A8%E6%80%81%E6%90%AC%E8%BF%90%23&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/O88zmcz9H">柯洁#柯柯抖音动态搬运# [打call][打call][打call] [图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-o88zmcz9h/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->柯洁<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E6%9F%AF%E6%9F%AF%E6%8A%96%E9%9F%B3%E5%8A%A8%E6%80%81%E6%90%AC%E8%BF%90%23&amp;amp;extparam=%23%E6%9F%AF%E6%9F%AF%E6%8A%96%E9%9F%B3%E5%8A%A8%E6%80%81%E6%90%AC%E8%25">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E6%9F%AF%E6%9F%AF%E6%8A%96%E9%9F%B3%E5%8A%A8%E6%80%81%E6%90%AC%E8%BF%90%23&amp;amp;extparam=%23%E6%9F%AF%E6%9F%AF%E6%8A%96%E9%9F%B3%E5%8A%A8%E6%80%81%E6%90%AC%E8%</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/O8bVNsH14">柯洁#野狐人气争霸赛##赛事预告# 第11期野狐人气争霸赛 8进4时间：4月7日下午三点地点：野狐围棋潜伏 vs 我想静静了（党毅飞九段） [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-o8bvnsh14/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->柯洁<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E9%87%8E%E7%8B%90%E4%BA%BA%E6%B0%94%E4%BA%89%E9%9C%B8%E8%B5%9B%23&amp;amp;extparam=%23%E9%87%8E%E7%8B%90%E4%BA%BA%E6%B0%94%E4%BA%89%E9%9C">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E9%87%8E%E7%8B%90%E4%BA%BA%E6%B0%94%E4%BA%89%E9%9C%B8%E8%B5%9B%23&amp;amp;extparam=%23%E9%87%8E%E7%8B%90%E4%BA%BA%E6%B0%94%E4%BA%89%E9%9C</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV1hq421w7YY">乃木坂46 38单under曲『車道側』</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv1hq421w7yy/">
    
    
    
    
    
      
    
    1<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV1um421J7yb">一方水土养一方狗，这怎么越看越像熊啊……</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv1um421j7yb/">
    
    
    
    
    
      
    
    一方水土养一方狗，这怎么越看越像熊啊……<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.npr.org/2024/04/04/1198908679/the-land-of-the-fee-throwback-04-04-2024">The Land of the Fee (Throwback)</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/www-npr-org-2024-04-04-1198908679-the-land-of-the-fee-throwback-04-04-2024/">
    
    
    
    
    
      
    
    Tipping is a norm in the United States—and it&rsquo;s always been controversial. The practice took off after the Civil War, as employers sought cheap labor from formerly enslaved people: if tips were expected, companies could get away with paying laughably low wages. But the practice was always controversial, and has been vehemently challenged since it first came to the U.S. from Europe. We speak with Nina Martyris, a journalist who&rsquo;s written about the history of tipping in the United States, to find out how tipping—once deemed a &ldquo;cancer in the breast of democracy&rdquo;— went from being considered &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.zhihu.com/pin/1759216205842669568">量子位发布了想法: Fusion Fund创始合伙人，斯坦福大学客座讲师张璐 确认参与 #中国AIGC产业峰会 ！&lt;br&gt;&lt;br&gt;张璐，Fusion Fund 创始合伙人，硅谷知名投资人、连...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/www-zhihu-com-pin-1759216205842669568/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/690701799">量子位发表了文章: 弱智吧竟成最佳中文AI训练数据？！中科院等：8项测试第一，远超知乎豆瓣小红书</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-690701799/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/690705482">量子位发表了文章: 英伟达AI新课爆火！免费学习，干货满满</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-690705482/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/690707398">量子位发表了文章: 腾讯开源视频生成新工具，论文还没发先上代码的那种</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-690707398/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/690712849">量子位发表了文章: 峰会报名中｜第二波嘉宾已就位，距离4月17日仅有两周</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-04</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-690712849/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

</main>
</div>

<script async src="//yihui.name/js/center-img.js"></script>

<footer>

<div class="footer">
  <ul class="menu">
    
    <li><a href="/"><span data-hover="Home">Home</span></a></li>
    
    <li><a href="/about/"><span data-hover="About">About</span></a></li>
    
    <li><a href="/archives/"><span data-hover="Archive">Archive</span></a></li>
    
    <li><a href="/contributor/"><span data-hover="Contributor">Contributor</span></a></li>
    
    <li><a href="/index.xml"><span data-hover="Subscribe">Subscribe</span></a></li>
    
  </ul>
  
  <div class="copyright">© <a href="https://rainoffallingstar.github.io">Fallingstar</a> 2023 | <a href="https://github.com/rainoffallingstar">Github</a></div>
  
</div>
</footer>







</body>
</html>

